PrairieView Partners’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-200
Closed 372
2023
Q3
$0 Hold
200
﹤0.01% 395
2023
Q2
$0 Hold
200
﹤0.01% 440
2023
Q1
$0 Hold
200
﹤0.01% 421
2022
Q4
$0 Hold
200
﹤0.01% 459
2022
Q3
$0 Hold
200
﹤0.01% 436
2022
Q2
$0 Hold
200
﹤0.01% 450
2022
Q1
$1K Hold
200
﹤0.01% 422
2021
Q4
$1K Hold
200
﹤0.01% 400
2021
Q3
$1K Hold
200
﹤0.01% 348
2021
Q2
$3K Hold
200
﹤0.01% 311
2021
Q1
$2K Buy
+200
New +$2.26K ﹤0.01% 329

Other funds holding CLOV

PrairieView Partners's CLOV Position: Q4 2023 in Review

PrairieView Partners sold out of Clover Health Investments (CLOV) in Q4 2023, closing a stake of 200 shares.

PrairieView Partners first reported a position in CLOV in Q1 2021 and held it in 11 quarters. The position peaked at $3K in Q2 2021. 144 funds tracked by Wall St. Rank hold CLOV as of Q4 2023.

  • PrairieView Partners reported no remaining Clover Health Investments position as of Q4 2023 after selling out during the quarter.
  • PrairieView Partners sold 200 Clover Health Investments shares in Q4 2023.
  • PrairieView Partners first reported a position in Clover Health Investments in Q1 2021 and held it in 11 quarters.
  • PrairieView Partners's Clover Health Investments position peaked at $3K in Q2 2021.
  • 144 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2023.

Based on PrairieView Partners's 13F filing for Q4 2023, filed 26 Jan 2024.